Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies
January 26, 2023• Latest, Most Popular, Roquefort, SLIDER, Top Stories, United Kingdom • One Comment
Roquefort Therapeutics (LSE: ROQ, OTCQB: ROQAF) (“Roquefort” or the “Company”) announces that two of its Midkine (MDK) antibody...
Read More → Read More: Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies